amyloidosis: results of a phase 1 dose-escalation study Weekly and twice-weekly bortezomib in patients with systemic AL
暂无分享,去创建一个
Y. Elsayed | G. Merlini | U. Hegenbart | G. Palladini | V. Sanchorawala | J. Fermand | A. Cakana | E. Reece | R. Vescio | Xiangyang Liu